EVEROLIMUS (Certican®)

Clinical Indication

Immunosuppressive therapy for Kidney Transplant in Adults and Children/Young People


In line with NICE TA 481, NICE TA 482

Date of classification

January 2018

Review date

January 2020


Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).